指南与共识关节外科

阿司匹林作为关节置换患者静脉血栓栓塞预防:临床实践指南推荐意见分析

Aspirin as Venous Thromboembolism Prophylaxis in Arthroplasty Patients: An Analysis of Clinical Practice Guidelines Recommendations.
指南 / 共识 · J Arthroplasty · 2024-05-24

该研究检索1966年至2024年1月的指南,纳入26部关于成人髋或膝关节置换平均风险住院患者静脉血栓栓塞预防的临床实践指南,其中5部推荐阿司匹林作为一线预防,11部推荐反对。发表年份较近的指南更可能推荐阿司匹林(OR 1.72,95%CI 1.05-2.84),更不可能推荐反对(OR 0.61,95%CI 0.41-0.90)。指南推荐不一致,需要足够把握度的随机对照试验。

要点

  • 26部指南中5部推荐阿司匹林作为一线预防,11部推荐反对。
  • 发表年份较近与推荐阿司匹林相关(OR 1.72,95%CI 1.05-2.84)。
  • 发表年份较近与推荐反对阿司匹林负相关(OR 0.61,95%CI 0.41-0.90)。

核心结论

  • 指南关于阿司匹林作为关节置换患者静脉血栓栓塞一线预防的推荐不一致。
  • 需要足够把握度的随机对照试验以更好地指导临床实践指南。

研究设计与样本

  • 检索MEDLINE、Embase、护理与联合健康文献累积索引及PubMed数据库,检索时间从1966年至2024年1月。
  • 纳入成人髋或膝关节置换平均风险住院患者静脉血栓栓塞预防的临床实践指南,由2名独立评价者收集指南特征。
  • 采用逻辑回归检验推荐或反对阿司匹林与指南特征之间的关联。

主要发现

  • 共纳入26部指南,发表于2003年2月至2023年9月。
  • 5部指南推荐阿司匹林作为一线治疗,11部指南推荐反对阿司匹林作为一线治疗。
  • 发表年份较近时,更可能推荐阿司匹林(OR 1.72,95%CI 1.05-2.84),更不可能推荐反对阿司匹林(OR 0.61,95%CI 0.41-0.90)。
  • 证据水平、指南工作组成员构成或指南目标等其他变量与推荐或反对阿司匹林均无关联。

关键数值与推荐

  • 推荐阿司匹林作为一线预防的指南有5部,推荐反对的有11部。
  • 发表年份较近与推荐阿司匹林相关(OR 1.72,95%CI 1.05-2.84)。
  • 发表年份较近与推荐反对阿司匹林负相关(OR 0.61,95%CI 0.41-0.90)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism (VTE) is a recognized postoperative complication of hip or knee arthroplasty and incurs major morbidity and mortality. While anticoagulants are the mainstay of chemoprophylaxis, aspirin has recently emerged as a popular prophylactic agent. However, there is a lack of high-quality evidence comparing aspirin to anticoagulants as a method of VTE prophylaxis, and current guidelines are conflicting regarding using aspirin as first-line chemoprophylaxis. We aimed to investigate guideline characteristics that are associated with the recommendation for or against aspirin as a first-line agent. METHODS: MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature, and PubMed databases were searched from 1966 to January 2024 to identify clinical practice guidelines for VTE prophylaxis in adult hip or knee arthroplasty inpatients of average risk. The characteristics of the guideline were collected by 2 independent reviewers. Logistic regression was used to test the association between the recommendation for or against aspirin and guideline characteristics. RESULTS: There were 26 guidelines published from February 2003 to September 2023 and included in this study. There were 5 guidelines that recommended aspirin and 11 guidelines that recommended against aspirin as first-line therapy. With a more recent year of publication, aspirin was more likely to be recommended (odds ratio 1.72, 95% confidence interval: 1.05 to 2.84) and less likely to be recommended against (odds ratio 0.61, 95% confidence interval: 0.41 to 0.90). No other variables, including the level of evidence used, the composition of the guideline working group, or the objective of the guideline, were associated with the recommendation for or against aspirin. CONCLUSIONS: Guidelines were inconsistent in their recommendations regarding aspirin as first-line therapy as VTE prophylaxis in arthroplasty patients. Adequately powered randomized controlled trials using modern practices, such as early postoperative mobilization, are needed to better inform clinical practice guidelines.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Lun KK, Tang M, Lewin A, et al. Aspirin as Venous Thromboembolism Prophylaxis in Arthroplasty Patients: An Analysis of Clinical Practice Guidelines Recommendations. J Arthroplasty. 2024. PMID: 38797455. doi:10.1016/j.arth.2024.05.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。